Lanza, M.; Basilotta, R.; Caccamo, A.; Casili, G.; Repici, A.; Oddo, S.; Esposito, E.
PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD. Cells 2025, 14, 1474.
https://doi.org/10.3390/cells14181474
AMA Style
Lanza M, Basilotta R, Caccamo A, Casili G, Repici A, Oddo S, Esposito E.
PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD. Cells. 2025; 14(18):1474.
https://doi.org/10.3390/cells14181474
Chicago/Turabian Style
Lanza, Marika, Rossella Basilotta, Antonella Caccamo, Giovanna Casili, Alberto Repici, Salvatore Oddo, and Emanuela Esposito.
2025. "PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD" Cells 14, no. 18: 1474.
https://doi.org/10.3390/cells14181474
APA Style
Lanza, M., Basilotta, R., Caccamo, A., Casili, G., Repici, A., Oddo, S., & Esposito, E.
(2025). PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD. Cells, 14(18), 1474.
https://doi.org/10.3390/cells14181474